Macroaxis considers Edwards Lifesciences not too risky given 1 month investment horizon. Edwards Lifesciences secures Sharpe Ratio (or Efficiency) of 0.5468 which denotes Edwards Lifesciences had 0.5468% of return per unit of risk over the last 1 month. Our philosophy towards predicting volatility of a stock is to use all available market data together with company specific technical indicators that cannot be diversified away. By reviewing Edwards Lifesciences technical indicators you can presently evaluate if the expected return of 0.5938% is justified by implied risk. Please utilize Edwards Lifesciences Standard Deviation of 1.15, Mean Deviation of 0.8252 and Coefficient Of Variation of 262.86 to check if our risk estimates are consistent with your expectations.
|Time Horizon||30 Days Login to change|
Edwards Lifesciences Technical Analysis
Projected Return Density Against MarketAllowing for the 30-days total investment horizon, Edwards Lifesciences has beta of 0.0 suggesting unless we do not have required data, the returns on DOW and Edwards Lifesciences are completely uncorrelated. Furthermore, Edwards Lifesciences CorporationIt does not look like Edwards Lifesciences alpha can have any bearing on the equity current valuation.
Predicted Return Density